Olipudase alfa treatment for pediatric acid sphingomyelinase deficiency in Egypt: A prospective, observational cohort study with an interventional subgroup
This case series contributes to the clinical and biochemical understanding of ASMD and may help reduce diagnostic delays and improve clinical management. Olipudase alfa was generally well tolerated, and promising clinical improvements were observed.
Authors
- Nehal Abdelaziz Arafa
- Iman Marzouk
- Shimaa Anwar
- Aml Mahfouz
Institutions
- Alexandria University (EG)
Publication Details
- Journal
- Molecular Genetics and Metabolism Reports
- Published
- 2026-02-11
- DOI
- https://doi.org/10.1016/j.ymgmr.2026.101293
- Primary Topic
- Sphingolipid Metabolism and Signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.00